Quantcast
Last updated on April 17, 2014 at 1:21 EDT
UCSF Launches Groundbreaking Online Registry To Drive Brain

UCSF Launches Groundbreaking Online Registry To Drive Brain Disease Research

Laura Kurtzman, UC San Francisco Brain Health Registry Brings Promise of Faster, Better Clinical Trials, New Treatments A new online project led by researchers at UC San Francisco promises to dramatically cut the time and cost of conducting...

Latest Pharmaceutical sciences Stories

2014-04-17 00:21:08

CHENGDU, China, April 16, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics, and active pharmaceutical ingredients (API), updated regarding the recent progress of the Jiangchuan Macrolide Facility (JCM). JCM has developed a new line of Azithromycin (Azi) API products that support steady monthly...

2014-04-16 23:16:23

KRS Global Biotechnology, Inc. a specialty pharmacy preparing drugs no longer commercially available or in short supply announces today that they have become a registered Outsourcing Facility under the new Compounding Quality Act. Boca Raton, FL (PRWEB) April 16, 2014 KRS Global Biotechnology, Inc. is pleased to announce that it has been recognized as a registered 503B Large-scale sterile compounding “Outsourcing Facility” by the Food & Drug Administration (FDA) under the Drug...

2014-04-16 23:10:31

High Throughput Screening (HTS) Market is expected to witness a high growth in the label-free technology segment, as this technology offers direct detection. http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html (PRWEB) April 16, 2014 According to the new market research report the “High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target...

2014-04-16 23:10:18

The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient. (PRWEB) April 16, 2014 The diabetes drug Actos has made news headlines this week after a jury decided that its manufacturer, Takeda, was responsible for causing bladder cancer in this case. But Actos is just one of several pioglitazone-containing drugs produced by Takeda and all of them...

2014-04-16 23:04:11

The industry will grow strongly as testing of new drugs continues. For this reason, industry research firm IBISWorld has added a report on the Contract Pharmaceutical Research Services industry to its growing industry report collection. New York, NY (PRWEB) April 16, 2014 The industry provides a breadth of research and development (R&D) services to manufacturers in the pharmaceutical industries. In the past five years, brand-name drug producers have faced increasing threats from...

2014-04-16 16:30:46

PITTSBURGH, April 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE(TM) (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day), the generic version of Janssen Pharmaceuticals Inc.'s ORTHO EVRA®* (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day). This product is indicated for the prevention of pregnancy in women who elect to use a transdermal patch...

2014-04-16 16:13:04

New screening technique opens the door to unlimited opportunities, both in terms of chemistry and biology research Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs. The corresponding author, Professor Ronald Quinn AM said testing the new process on a marine sponge had delivered not only confirmation that the system is effective, but also a potential lead in the...

2014-04-16 12:29:54

PLYMOUTH MEETING, Pa., April 16, 2014 /PRNewswire/ -- ePharmaSolutions, a leading provider of eClinical solutions announced the results of the initial pilot studies for its patient matching and triaging solution, ReferralPlus(TM), that suggest a significant improvement in match rates for people who are actively searching for clinical trials in which to participate. "We are absolutely thrilled with the results of these pilots and want to thank all of the pharmaceutical companies who helped...

2014-04-16 12:29:46

CHESTERFIELD, Mo., April 16, 2014 /PRNewswire/ -- Amid the FDA and ASHP announced shortages of unapproved Neostigmine Methylsulfate Injection; Eclat Pharmaceuticals is effectively ending the shortages with BLOXIVERZ®, the only FDA-approved Neostigmine Methylsulfate Injection. http://photos.prnewswire.com/prnvar/20140416/74458 BLOXIVERZ is available in two dosage strengths, 0.5 mg/mL and 1 mg/mL, in 10 mL multiple dose vials. All other Neostigmine Methylsulfate Injections are not...

2014-04-16 12:29:41

CHARLOTTE, N.C., April 16, 2014 /PRNewswire/ -- On April 10, 2014 the U.S. Food & Drug Administration (FDA) issued a "Closeout" letter to Prodigy Diabetes Care to formally conclude the regulatory action that resulted in a Warning Letter on February 22, 2013. Since the original site inspection of Prodigy in March 2012, and in response to the February 2013 letter, Prodigy has worked with the FDA to address and correct the issues identified through that inspection. The FDA Atlanta...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »